Lv4
570 积分 2023-11-29 加入
From KRASG12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
2天前
已完结
Emerging landscape of KRAS inhibitors in cancer treatment
1个月前
已完结
Population-scale sequencing resolves determinants of persistent EBV DNA
1个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
2个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
3个月前
已完结
A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction
4个月前
已完结
Structure-based design of macrocyclic peptides to generate functional antibodies against G protein-coupled receptors
4个月前
已完结
Targeted protein degradation in the transmembrane and extracellular space
4个月前
已完结
Structure-Based Development of a Novel Macrocyclic Peptide to Disrupt the Lumican–Collagen I Interaction in Liver Fibrosis
4个月前
已完结
皖公网安备34019202002308
